Skip to main content
Fig. 5 | BMC Medical Research Methodology

Fig. 5

From: The necessity of validity diagnostics when drawing causal inferences from observational data: lessons from a multi-database evaluation of the risk of non-infectious uveitis among patients exposed to Remicade®

Fig. 5

Attrition diagram for rheumatoid arthritis (RA); patient attrition counts and proportions after sequential design choices applied in the Optum® EHR database

Key – Target: patients with RA newly exposed to Remicade®, Comparator: patients with RA newly exposed to golimumab, certolizumab pegol, ustekinumab, vedolizumab]

Back to article page